Arena Pharmaceuticals Inc's Form 4 filing
Longboard Pharmaceuticals, Inc. (LBPH) · filed Jan 29, 2024
- Accession no.
- 0000078003-24-000012
- Filed
- Jan 29, 2024
- Trade date
- Jan 25, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $96.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arena Pharmaceuticals IncCIK 0001080709 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 | Voting Common Stock | SSaleDisposed | −3,978,540 | $24.25F1 | −$96,479,595 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The per share price is reported before fees.
Referenced by the price of 1 transaction in Table I.